Dr Charles F Kattuah, DDS | |
922 H St, Marysville, CA 95901-5126 | |
(530) 741-9411 | |
Not Available |
Full Name | Dr Charles F Kattuah |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 922 H St, Marysville, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952315442 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 46619 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Charles F Kattuah, DDS 922 H St, Marysville, CA 95901-5126 Ph: () - | Dr Charles F Kattuah, DDS 922 H St, Marysville, CA 95901-5126 Ph: (530) 741-9411 |
News Archive
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that compared to last year's analysis of U.S. patient-level claims data, TNF-alpha inhibitors are being used more often to treat newly diagnosed patients suffering from Crohn's disease.
Helix BioMedix, Inc., a developer of bioactive peptides, today announced the completion of a series of three clinical studies investigating the safety and efficacy of a serum, eye cream and moisturizer, each containing the Company's SmartPeptides™ technology, including the newly developed Heptapeptide-7. These studies demonstrate improvement in skin texture and appearance as well as the decrease in fine lines and wrinkles with Striking™ Skin Care formulations.
Imagine that while eating a delicious meal at your favorite restaurant, your joy is cut short because of difficulty swallowing your food, followed by chest pain.
A three-year follow-up study of patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial revealed that increased mortality among patients with advanced chronic hepatitis C who received long-term peginterferon therapy was attributed to non-liver related causes and occurred primarily in patients with bridging fibrosis. No pattern to this excess mortality was evident to researchers, but deaths were unrelated to the peginterferon treatment. Full findings are published in the April issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 2 days ago
Dr. Aicha Benbrahim, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1601 B St Ste A, Marysville, CA 95901 Phone: 530-741-1048 | |
Rogelio Avalos Barrera, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 812 4th St, Suite E, Marysville, CA 95901 Phone: 530-742-6971 | |
Dr. Ernest Lawrence Garcia Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 518 J St, Marysville, CA 95901 Phone: 530-742-2461 Fax: 530-742-2464 |